Resistin increases monolayer permeability of human coronary artery endothelial cells

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Jamaluddin, Md Saha ^a   Yan, Shaoyu ^a   Lü, Jianming ^a   Liang, Zhengdong ^a   Yao, Qizhi ^a   Chen, Changyi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN ZO1; RESISTIN; RETN PROTEIN, HUMAN; SUPEROXIDE DISMUTASE; TJP1 PROTEIN, HUMAN;

CAPILLARY PERMEABILITY; CELL CULTURE; CORONARY BLOOD VESSEL; CYTOLOGY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; METABOLISM; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

CAPILLARY PERMEABILITY; CELLS, CULTURED; CORONARY VESSELS; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HUMANS; MAP KINASE SIGNALING SYSTEM; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RESISTIN; RNA, MESSENGER; SUPEROXIDE DISMUTASE; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84893572120     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084576     Document Type: Article

References (76)

1. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, et al. (2001) Resistin/Fizz3 expression in relation to obesity and peroxisome proliferatoractivated receptor-gamma action in humans. Diabetes 50: 2199-2202. (Pubitemid 33641901)
2. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, et al. (2001) The hormone resistin links obesity to diabetes. Nature 409: 307-312. (Pubitemid 32151228)
3. Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, et al. (2001) A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A 98: 502-506. (Pubitemid 32105071)
4. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, et al. (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19: 4046-4055. (Pubitemid 30608543)
5. Laudes M, Oberhauser F, Schulte DM, Freude S, Bilkovski R, et al. (2010) Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans. Horm Metab Res 42: 268-273.
6. Fain JN, Cheema PS, Bahouth SW, Lloyd Hiler M (2003) Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 300: 674-678. (Pubitemid 36268889)
7. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, et al. (2003) Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 300: 472-476. (Pubitemid 38375833)
8. Tsiotra PC, Boutati E, Dimitriadis G, Raptis SA (2013) High insulin and leptin increase resistin and inflammatory cytokine production from human mononuclear cells. Biomed Res Int 2013: 487081.
9. Ohmori R, Momiyama Y, Kato R, Taniguchi H, Ogura M, et al. (2005) Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol 46: 379-380. (Pubitemid 40966873)
10. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, et al. (2005) Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111: 932-939. (Pubitemid 40279897)
11. Fang C, Lei J, Zhou SX, Zhang YL, Yuan GY, et al. (2013) Association of higher resistin levels with inflammatory activation and endothelial dysfunction in patients with essential hypertension. Chin Med J (Engl) 126: 646-649.
12. Pang L, Zhang Y, Yu Y, Zhang S (2013) Resistin promotes the expression of vascular endothelial growth factor in ovary carcinoma cells. Int J Mol Sci 14: 9751-9766.
13. Menzaghi C, Bacci S, Salvemini L, Mendonca C, Palladino G, et al. (2013) Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes. PLoS One 8: e64729.
14. Groeneveld AB (2002) Vascular pharmacology of acute lung injury and acute respiratory distress syndrome. Vascul Pharmacol 39: 247-256.
15. McDonald DM, Baluk P (2002) Significance of blood vessel leakiness in cancer. Cancer Res 62: 5381-5385. (Pubitemid 35024617)
16. Krouwer VJ, Hekking LH, Langelaar-Makkinje M, Regan-Klapisz E, Post JA (2012) Endothelial cell senescence is associated with disrupted cell-cell junctions and increased monolayer permeability. Vasc Cell 4: 12.
17. Steinberg D (1997) A critical look at the evidence for the oxidation of LDL in atherogenesis. Atherosclerosis 131 Suppl: S5-7.
18. Antonetti DA, Wolpert EB, DeMaio L, Harhaj NS, Scaduto RC Jr (2002) Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem 80: 667-677. (Pubitemid 34809975)
19. Jiang WG, Bryce RP, Horrobin DF, Mansel RE (1998) Regulation of tight junction permeability and occludin expression by polyunsaturated fatty acids. Biochem Biophys Res Commun 244: 414-420. (Pubitemid 28414097)
20. Stelwagen K, McFadden HA, Demmer J (1999) Prolactin, alone or in combination with glucocorticoids, enhances tight junction formation and expression of the tight junction protein occludin in mammary cells. Mol Cell Endocrinol 156: 55-61. (Pubitemid 29460744)
21. Bolton SJ, Anthony DC, Perry VH (1998) Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience 86: 1245-1257. (Pubitemid 28318549)
22. Harhaj NS, Barber AJ, Antonetti DA (2002) Platelet-derived growth factor mediates tight junction redistribution and increases permeability in MDCK cells. J Cell Physiol 193: 349-364. (Pubitemid 35265954)
23. Matter K, Balda MS (2003) Signalling to and from tight junctions. Nat Rev Mol Cell Biol 4: 225-236. (Pubitemid 36288044)
24. Spindler V, Schlegel N, Waschke J (2010) Role of GTPases in control of microvascular permeability. Cardiovasc Res 87: 243-253.
25. Terry S, Nie M, Matter K, Balda MS (2010) Rho signaling and tight junction functions. Physiology (Bethesda) 25: 16-26.
26. Tsukita S, Furuse M, Itoh M (1999) Structural and signalling molecules come together at tight junctions. Curr Opin Cell Biol 11: 628-633. (Pubitemid 29460406)
27. Chen C, Jamaluddin MS, Yan S, Sheikh-Hamad D, Yao Q (2008) Human stanniocalcin-1 blocks TNF-alpha-induced monolayer permeability in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 28: 906-912. (Pubitemid 351544106)
28. Yan S, Wang X, Chai H, Wang H, Yao Q, et al. (2006) Secretoneurin increases monolayer permeability in human coronary artery endothelial cells. Surgery 140: 243-251. (Pubitemid 44176069)
29. Yan S, Chai H, Wang H, Yang H, Nan B, et al. (2005) Effects of lysophosphatidylcholine on monolayer cell permeability of human coronary artery endothelial cells. Surgery 138: 464-473. (Pubitemid 41415574)
30. Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844.
31. Kondo T, Hirose M, Kageyama K (2009) Roles of oxidative stress and redox regulation in atherosclerosis. J Atheroscler Thromb 16: 532-538.
32. Chen C, Lu XH, Yan S, Chai H, Yao Q (2005) HIV protease inhibitor ritonavir increases endothelial monolayer permeability. Biochem Biophys Res Commun 335: 874-882. (Pubitemid 41188279)
33. Jamaluddin MS, Lin PH, Yao Q, Chen C (2010) Non-nucleoside reverse transcriptase inhibitor efavirenz increases monolayer permeability of human coronary artery endothelial cells. Atherosclerosis 208: 104-111.
34. Jamaluddin MS, Wang X, Wang H, Rafael C, Yao Q, et al. (2009) Eotaxin increases monolayer permeability of human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 29: 2146-2152.
35. Hogan SP, Seidu L, Blanchard C, Groschwitz K, Mishra A, et al. (2006) Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J Allergy Clin Immunol 118: 257-268. (Pubitemid 43946483)
36. Langheim S, Dreas L, Veschini L, Maisano F, Foglieni C, et al. (2010) Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome. Am J Physiol Heart Circ Physiol 298: H746-753.
37. Bazzoni G (2006) Endothelial tight junctions: permeable barriers of the vessel wall. Thromb Haemost 95: 36-42.
38. Bazzoni G, Dejana E (2004) Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84: 869-901. (Pubitemid 38823769)
39. Dejana E, Tournier-Lasserve E, Weinstein BM (2009) The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 16: 209-221.
40. Steed E, Balda MS, Matter K (2010) Dynamics and functions of tight junctions. Trends Cell Biol 20: 142-149.
41. Stevens T, Garcia JG, Shasby DM, Bhattacharya J, Malik AB (2000) Mechanisms regulating endothelial cell barrier function. Am J Physiol Lung Cell Mol Physiol 279: L419-422.
42. van Nieuw Amerongen GP, van Hinsbergh VW (2002) Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vascul Pharmacol 39: 257-272.
43. Runkle EA, Mu D (2013) Tight junction proteins: From barrier to tumorigenesis. Cancer Letters 337: 41-48.
44. Boueiz A, Hassoun PM (2009) Regulation of endothelial barrier function by reactive oxygen and nitrogen species. Microvasc Res 77: 26-34.
45. Eiserich JP, Estevez AG, Bamberg TV, Ye YZ, Chumley PH, et al. (1999) Microtubule dysfunction by posttranslational nitrotyrosination of alpha-tubulin: a nitric oxide-dependent mechanism of cellular injury. Proc Natl Acad Sci U S A 96: 6365-6370. (Pubitemid 29256671)
46. Pai AB, Patel H, Prokopienko AJ, Alsaffar H, Gertzberg N, et al. (2012) Lipoteichoic acid from Staphylococcus aureus induces lung endothelial cell barrier dysfunction: Role of reactive oxygen and nitrogen species. PLoS ONE 7: e49209.
47. Parinandi NL, Kleinberg MA, Usatyuk PV, Cummings RJ, Pennathur A, et al. (2003) Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells. Am J Physiol Lung Cell Mol Physiol 284: L26-38. (Pubitemid 35471255)
48. Wojciak-Stothard B, Entwistle A, Garg R, Ridley AJ (1998) Regulation of TNF-alpha-induced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and Cdc42 in human endothelial cells. J Cell Physiol 176: 150-165. (Pubitemid 28277205)
49. Baldwin AL, Thurston G, al Naemi H (1998) Inhibition of nitric oxide synthesis increases venular permeability and alters endothelial actin cytoskeleton. Am J Physiol 274: H1776-1784.
50. Rochette L, Lorin J, Zeller M, Guilland JC, Lorgis L, et al. (2013) Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets? Pharmacol Ther 140: 239-257.
51. Force T, Pombo CM, Avruch JA, Bonventre JV, Kyriakis JM (1996) Stressactivated protein kinases in cardiovascular disease. Circ Res 78: 947-953. (Pubitemid 26166702)
52. Hoefen RJ, Berk BC (2002) The role of MAP kinases in endothelial activation. Vascul Pharmacol 38: 271-273. (Pubitemid 36398260)
53. New L, Han J (1998) The p38 MAP kinase pathway and its biological function. Trends Cardiovasc Med 8: 220-228. (Pubitemid 28345826)
54. Sugden PH, Clerk A (1998) "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res 83: 345-352. (Pubitemid 28389964)
55. Yoshizumi M, Kyotani Y, Zhao J, Nagayama K, Ito S, et al. (2012) Role of big mitogen-activated protein kinase 1 (BMK1)/extracellular signal-regulated kinase 5 (ERK5) in the pathogenesis and progression of atherosclerosis. J Pharmacol Sci 120: 259-263.
56. Wu T, Xing J, Birukova AA (2013) Cell-type-specific crosstalk between p38 MAPK and Rho signaling in lung micro- and macrovascular barrier dysfunction induced by Staphylococcus aureus-derived pathogens. Transl Res 162: 45-55.
57. Chen C, Jiang J, Lü JM, Chai H, Wang X, et al. (2010) Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol 299: H193-201.
58. Tarkowski A, Bjersing J, Shestakov A, Bokarewa MI (2010) Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med 14: 1419-1431.
59. Beutler B (2004) Inferences,questions and possibilities in Toll-like receptor signaling. Nature 430: 257-263.
60. Lin FY, Chen YH, Tasi JS, Chen JW, Yang TL, et al. (2006) Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways. Arterioscler Thromb Vasc Biol 26: 2630-2637.
61. Huang H, Rose JL, Hoyt DG (2004) p38 Mitogen-activated protein kinase mediates synergistic induction of inducible nitric-oxide synthase by lipopolysaccharide and interferon-γ through signal transducer and activator of transcription 1 Ser727 phosphorylation in murine aortic endothelial cells. Mol Pharmacol 66: 302-311. (Pubitemid 38989487)
62. Laird MH, Rhee SH, Perkins DJ, Medvedev AE, Piao W, et al. (2009) TLR4/MyD88/PI3K interactions regulate TLR4 signaling. J Leukoc Biol 85: 966-977.
63. Chen Q, Powell DW, Rane MJ, Singh S, Butt W, et al. (2003) Akt phosphorylates p47phox and mediates respiratory burst activity in human neutrophils. J Immunol 170: 5302-5308. (Pubitemid 36554765)
64. Kwon T, Kwon DY, Chun J, Kim JH, Kang SS (2000) Akt protein kinase inhibits Rac1-GTP binding through phosphorylation at serine 71 of Rac1. J Biol Chem 275: 423-428. (Pubitemid 30039001)
65. Diekmann D, Abo A, Johnston C, Segal AW, Hall A (1994) Interaction of Rac with p67phox and regulation of phagocytic NADPH oxidase activity. Science 265: 531-533.
66. Pacquelet S, Johnson JL, Ellis BA, Brzezinska AA, Lane WS, et al. (2007) Crosstalk between IRAK-4 and the NADPH oxidase. Biochem J 403; 451-461.
67. Kennedy NJ, Cellurale C, Davis RJ (2007) A radical role for p38 MAPK in tumor initiation. Cancer Cell, 11: 101-103. (Pubitemid 46209855)
68. Zhou X, Ferraris JD, Dmitrieva NI, Liu Y, Burg MB (2008) MKP-1 inhibits high NaCl-induced activation of p38 but does not inhibit the activation of TonEBP/OREBP: Opposite roles of p38α and p38δ. Proc Natl Acad Sci U S A 105: 5620-5625. (Pubitemid 351753912)
69. Mayr B,Montminy M (2001) Transcriptional regulation by the phosphorylationdependent factor CREB. Nat Rev Mol Cell Biol 2: 599-609. (Pubitemid 33674011)
70. Deak M, Clifton AA D, Lucocq J, Alessi DR (1998) Mitogen- and stressactivated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J 17: 4426-4441. (Pubitemid 28362632)
71. Tan Y, Rouse J, Zhang A, Cariati S, Cohen P, et al. (1996) FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J 15: 4629-4642. (Pubitemid 26294581)
72. Xing J, Kornhauser JM, Xia Z, Thiele EA, Greenberg ME (1998) Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol Cell Biol 18: 1946-1955. (Pubitemid 28152643)
73. Sudo T, Kawai K, Matsuzaki H, Osada H (2005) p38 mitogen-activated protein kinase plays a key role in regulating MAPKAPK2 expression. Biochem Biophys Res Commun 337: 415-421. (Pubitemid 41429300)
74. Zhong Y, Zhang B, Eum SY, Toborek M (2012) HIV-1 Tat triggers nuclear localization of ZO-1 via Rho signaling and cAMP response element-binding protein activation. J Neurosci 32: 143-150.
75. Chen J, Xiao L, Rao JN, Zou T, Liu L, et al. (2008) JunD represses transcription and translation of the tight junction protein zona occludens-1 modulating intestinal epithelial barrier function. Mol Biol Cell 19: 3701-3712.
76. Tapryal N, Mukhopadhyay C, Das D, Fox PL (2009), Mukhopadhyay CK. Reactive oxygen species regulate ceruloplasmin by a novel mRNA decay mechanism involving its 39-untranslated region: implications in neurodegenerative diseases. J Biol Chem 284: 1873-1883.